Moberg Pharma AB (publ) (STO:MOB)

Market Cap	423.24M
Revenue (ttm)	12.50M
Net Income (ttm)	-257.79M
Shares Out	47.00M
EPS (ttm)	-5.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,128
Average Volume	86,703
Open	8.50
Previous Close	9.10
Day's Range	8.50 - 9.19
52-Week Range	6.34 - 16.46
Beta	1.08
RSI	51.33
Earnings Date	Nov 11, 2025

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 10
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MOB